Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages

  Bierkens, Mariska ^a   Wilting, Saskia M ^a   Van Wieringen, Wessel N ^a,b   Van Kemenade, Folkert J ^a   Bleeker, Maaike C G ^a   Jordanova, Ekaterina S ^a   Bekker Lettink, Marjolein ^a   Van De Wiel, Mark A ^a   Ylstra, Bauke ^a   Meijer, Chris J L M ^a   Snijders, Peter J F ^a   Steenbergen, Renske D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

arrayCGH; cervical cancer; high grade cervical intraepithelial neoplasia; HPV

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS;

EID: 84858285367     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26496     Document Type: Article

References (22)

1. zur Hausen H,. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8. (Pubitemid 30365529)
2. Baseman JG, Koutsky LA,. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 (Suppl 1): S16-S24. (Pubitemid 40332585)
3. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ,. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208: 152-64. (Pubitemid 43126109)
4. Moody CA, Laimins LA,. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-60.
5. Wentzensen N, von Knebel Doeberitz M,. Biomarkers in cervical cancer screening. Dis Markers 2007; 23: 315-30. (Pubitemid 47015791)
6. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC,. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-34.
7. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010; 102: 315-24.
8. Wilting SM, Steenbergen RD, Tijssen M, Van Wieringen WN, Helmerhorst TJ, van Kemenade FJ, Bleeker MC, van de Wiel MA, Carvalho B, Meijer GA, Ylstra B, Meijer CJ, et al. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res 2009; 69: 647-55.
9. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van GK, Boon ME, Ruitinga W, van BM, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72. (Pubitemid 350137476)
10. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ,. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87. (Pubitemid 34208623)
11. Van Wieringen WN, van de Wiel MA, Ylstra B,. Weighted clustering of called array CGH data. Biostatistics 2008; 9: 484-500. (Pubitemid 351882087)
12. Smeets SJ, Brakenhoff RH, Ylstra B, Van Wieringen WN, van de Wiel MA, Leemans CR, Braakhuis BJ,. Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol 2009; 31: 291-300.
13. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H,. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002; 33: 98-102.
14. Alazawi W, Pett M, Strauss S, Moseley R, Gray J, Stanley M, Coleman N,. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br J Cancer 2004; 91: 2063-70. (Pubitemid 40128773)
15. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Philip J, Lundsteen C,. Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet Cytogenet 2001; 129: 47-51. (Pubitemid 32743379)
16. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T,. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996; 93: 479-84. (Pubitemid 26038181)
17. Narayan G, Bourdon V, Chaganti S, rias-Pulido H, Nandula SV, Rao PH, Gissmann L, Durst M, Schneider A, Pothuri B, Mansukhani M, Basso K, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007; 46: 373-84. (Pubitemid 46411328)
18. Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, Van Wieringen WN, Braakhuis BJ, Meijer GA, Ylstra B, Snijders PJ, Steenbergen RD,. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 2008; 47: 890-905.
19. Shroyer KR, Homer P, Heinz D, Singh M,. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 2006; 108: 324-30. (Pubitemid 44583712)
20. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-97. (Pubitemid 47598401)
21. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E,. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-98. (Pubitemid 43208905)
22. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del MA, Ghiringhello B, Girlando S, Gillio-Tos A, De ML, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.